Key Financial Data Of Reporting Company

SAPPORO CLINICAL LABORATORY INC. - Filing #7353045

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
14,852,697,000 JPY
20,127,692,000 JPY
15,250,105,000 JPY
Ordinary profit (loss)
417,882,000 JPY
1,159,449,000 JPY
971,637,000 JPY
Net assets
11,101,818,000 JPY
10,880,986,000 JPY
10,814,977,000 JPY
Total assets
16,935,020,000 JPY
16,521,281,000 JPY
16,893,292,000 JPY
Basic earnings (loss) per share
93.67
25.72
170.53
147.85
70.53
Diluted earnings per share
Equity-to-asset ratio
0.640 xbrli:pure
0.641 xbrli:pure
0.622 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.